Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to -$10.2 million.

  • Medifast's Net Cash Flow rose 5805.0% to -$10.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.6 million, marking a year-over-year increase of 5422.87%. This contributed to the annual value of -$1.6 million for FY2025, which is 5422.87% up from last year.
  • According to the latest figures from Q4 2025, Medifast's Net Cash Flow is -$10.2 million, which was up 5805.0% from -$2.2 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Net Cash Flow registered a high of $42.2 million during Q1 2021, and its lowest value of -$57.1 million during Q2 2022.
  • For the 5-year period, Medifast's Net Cash Flow averaged around -$3.7 million, with its median value being $1.9 million (2024).
  • Data for Medifast's Net Cash Flow shows a peak YoY increase of 20824.82% (in 2021) and a maximum YoY decrease of 79352.17% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Medifast's Net Cash Flow stood at -$50.3 million in 2021, then soared by 136.46% to $18.3 million in 2022, then crashed by 198.75% to -$18.1 million in 2023, then plummeted by 34.59% to -$24.4 million in 2024, then soared by 58.05% to -$10.2 million in 2025.
  • Its last three reported values are -$10.2 million in Q4 2025, -$2.2 million for Q3 2025, and $10.0 million during Q2 2025.